newsfilter
← Latest News
PR Newswire·

Cellular Biomedicine Group Announces Q4 and Full Year 2019 Financial Results and Recent Operational Progress

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of...